with 98% of people ages 12-64 and 87% of people 65+ developing an immune response.
In fact, most had developed a response by Day 15 (97% for people 12-64 and 82% for people 65+).
Results showed most people (86% for ages 12-64 and 76% for ages 65+) still had a response at 6 months, so you can help protect yourself on longer trips, add an extra destination, or even get vaccinated a few months in advance.
Mostly mild to moderate side effects
The most common side effects were pain at the injection site, fatigue, headache, and muscle pain.
Approved for travelers
ages 12 and over
HELP PROTECT YOURSELF FROM CHIKUNGUNYA WITH 1 SHOT
Now you can take on chikungunya, no matter where your travels take you. With VIMKUNYA.
get VIMKUNYA
Video Transcript
Virus-like particles, or VLPs, are a modern way to create recombinant vaccines.
Instead of using any viral genetic material, VLP technology uses protein particles to mimic the structure of live viruses.
These protein particles self-assemble around a central structure, into a shape that resembles the virus.
Once inside the body, the virus-like shape triggers an immune response, teaching our immune system how to react if the real virus attacks— but with no risk of infecting cells or causing disease.
WHAT MAKES VIMKUNYA DIFFERENT
VIMKUNYA is a virus-like
particle (VLP) vaccine and contains NO viral genetic material
VIMKUNYA is a VLP vaccine that mimics the chikungunya virus without ever exposing your body to the live virus.
Since VIMKUNYA does not contain any viral genetic material, it's not infectious.
What is VIMKUNYA?
VIMKUNYA is a vaccine for prevention of disease caused by chikungunya virus in people 12 years of age and older.
Additional clinical trials are required to confirm the clinical profile.
Important Safety Information
You should not get VIMKUNYA if you are allergic to any of the ingredients of the vaccine or if you have had an allergic reaction following a previous dose of VIMKUNYA.
People with a lowered immune system, including people receiving medications that affect the immune system, may have a diminished response to VIMKUNYA. Tell your healthcare provider about all medications you are taking.
Fainting may occur with administration of injected vaccines including VIMKUNYA.
The most common side effects were pain at the injection site, fatigue, headache, and muscle pain. These are not all the possible side effects.
Tell your healthcare provider if you are pregnant, planning to become pregnant, or are breastfeeding.
Tell your healthcare provider about any side effects that concern you. To report SUSPECTED ADVERSE REACTIONS, contact Bavarian Nordic at 1-844-4BAVARIAN or the US Department of Health and Human Services by visiting www.vaers.hhs.gov/reportevent.html or call 1-800-822-7967.
Please see full Prescribing Information here.
What is VIMKUNYA?
VIMKUNYA is a vaccine for prevention of disease caused by chikungunya virus in people 12 years of age and older.
Additional clinical trials are required to confirm the clinical profile.
Important Safety Information
You should not get VIMKUNYA if you are allergic to any of the ingredients of the vaccine or if you have had an allergic reaction following a previous dose of VIMKUNYA.
People with a lowered immune system, including people receiving medications that affect the immune system, may have a diminished response to VIMKUNYA. Tell your healthcare provider about all medications you are taking.
Fainting may occur with administration of injected vaccines including VIMKUNYA.
The most common side effects were pain at the injection site, fatigue, headache, and muscle pain. These are not all the possible side effects.
Tell your healthcare provider if you are pregnant, planning to become pregnant, or are breastfeeding.
Tell your healthcare provider about any side effects that concern you. To report SUSPECTED ADVERSE REACTIONS, contact Bavarian Nordic at 1-844-4BAVARIAN or the US Department of Health and Human Services by visiting www.vaers.hhs.gov/reportevent.html or call 1-800-822-7967.
Please see full Prescribing Information here.